Related Experiment Videos
Efficacy of levocabastine in conjunctival provocation studies
1Janssen Research Foundation, Beerse, Belgium.
Documenta Ophthalmologica. Advances in Ophthalmology
|January 1, 1992
Summary
Levocabastine eye drops offer rapid and long-lasting relief from ocular allergy symptoms. This histamine H1 antagonist effectively reduced itching, redness, and swelling within 10 minutes, outperforming cromoglycate.
Area of Science:
- Ophthalmology
- Allergology
- Pharmacology
Background:
- Levocabastine is a novel topical histamine H1 receptor antagonist.
- Histamine H1 antagonists are crucial in managing allergic conjunctivitis.
Purpose of the Study:
- To evaluate the antihistaminic and antiallergic efficacy of levocabastine eye drops.
- To assess the onset and duration of action of levocabastine in ocular provocation models.
Main Methods:
- Eight conjunctival provocation studies involving 238 participants.
- Challenges included histamine, allergen (including compound 48/80), or both.
- Levocabastine (single dose) compared against placebo and/or cromoglycate.
Main Results:
- Single levocabastine eye drop instillation provided rapid (within 10 minutes) protection against induced ocular symptoms.
- Significant alleviation of conjunctival itching, redness, chemosis, eyelid swelling, and tearing (p ≤ 0.05).
- Levocabastine demonstrated sustained activity for at least four hours and increased allergen threshold, outperforming cromoglycate.
Conclusions:
- Conjunctival provocation studies confirm levocabastine eye drops provide rapid and enduring protection against histamine or allergen-induced conjunctival symptoms.
- Levocabastine exhibits superior efficacy compared to cromoglycate, even with single-dose administration versus multi-week treatment.